Get started
Author

Lydie Lemonnier

Observed names: L Lemonnier, L. Lemonnier, L. Lemonnier-Videau, Lemonnier, Lydie, Lydie LEMONNIER, Lydie Lemmonier, Lydie Lemonnier-Videau
Observed institutions: The Alfred Hospital, Children's Health Ireland at Crumlin, Centre Hospitalier Universitaire de Montpellier, Vaincre la Mucoviscidose, Centre Hospitalier Universitaire Brugmann, UniCancer Group, Hôpital Arnaud de Villeneuve, Federal Medical-Biological Agency
ORCID: 0000-0002-6351-4899
Observed ORCID: 0000-0002-6351-4899
OpenAlex ID: A5103957202
Multicenter Study of Prevalence of Nontuberculous Mycobacteria in Patients with Cystic Fibrosis in France
2009 · Anne-Laure Roux, Emilie Catherinot, et al. · Journal of Clinical Microbiology · 335
Rapid Improvement after Starting Elexacaftor–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease
2021 · Pierre-Régis Burgel, Isabelle Durieu, et al. · American Journal of Respiratory and Critical Care Medicine · 284
Real-Life Safety and Effectiveness of Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis
2019 · Pierre-Régis Burgel, Anne Munck, et al. · American Journal of Respiratory and Critical Care Medicine · 138
Causes of death in French cystic fibrosis patients: The need for improvement in transplantation referral strategies!
2015 · Clémence Martin, Cécile Hamard, et al. · Journal of Cystic Fibrosis · 108
Mycobacterium avium and Mycobacterium abscessus complex target distinct cystic fibrosis patient subpopulations
2012 · Emilie Catherinot, Anne-Laure Roux, et al. · Journal of Cystic Fibrosis · 108
PDF
The French Compassionate Program of elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis with advanced lung disease and no F508del CFTR variant
2023 · Pierre-Régis Burgel, Isabelle Sermet-Gaudelus, et al. · European Respiratory Journal · 107
Comparing Mycobacterium massiliense and Mycobacterium abscessus lung infections in cystic fibrosis patients
2014 · Anne-Laure Roux, Emilie Catherinot, et al. · Journal of Cystic Fibrosis · 105
CFTR-France, a national relational patient database for sharing genetic and phenotypic data associated with rareCFTRvariants
2017 · Mireille Claustres, Corinne Thèze, et al. · Human Mutation · 101
PDF
Theratyping cystic fibrosis patients to guide elexacaftor/tezacaftor/ivacaftor out-of-label prescription
2023 · Elise Dreano, Pierre Régis Burgel, et al. · European Respiratory Journal · 96
The expanded French compassionate programme for elexacaftor–tezacaftor–ivacaftor use in people with cystic fibrosis without a F508del CFTR variant: a real-world study
2024 · Pierre-Régis Burgel, Isabelle Sermet-Gaudelus, et al. · The Lancet Respiratory Medicine · 67
PDF
Sustained effectiveness of elexacaftor-tezacaftor-ivacaftor in lung transplant candidates with cystic fibrosis
2022 · Clémence Martin, Martine Reynaud-Gaubert, et al. · Journal of Cystic Fibrosis · 67
Retrospective observational study of French patients with cystic fibrosis and a Gly551Asp-CFTR mutation after 1 and 2 years of treatment with ivacaftor in a real-world setting
2017 · Dominique Hubert, Clémence Dehillotte, et al. · Journal of Cystic Fibrosis · 63
Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020
2021 · Lutz Naehrlich, Annalisa Orenti, et al. · Journal of Cystic Fibrosis · 61
PDF
Survival estimates in European cystic fibrosis patients and the impact of socioeconomic factors: a retrospective registry cohort study
2021 · Edward F. McKone, Cono Ariti, et al. · European Respiratory Journal · 60
PDF
Pregnancy outcome in women with cystic fibrosis and poor pulmonary function
2019 · Quitterie Reynaud, Christine Rousset Jablonski, et al. · Journal of Cystic Fibrosis · 51
PDF
First Wave of COVID-19 in French Patients with Cystic Fibrosis
2020 · Harriet Corvol, Sandra de Miranda, et al. · Journal of Clinical Medicine · 46
PDF
Inhaled therapies, azithromycin andMycobacterium abscessusin cystic fibrosis patients
2012 · Emilie Catherinot, Anne-Laure Roux, et al. · European Respiratory Journal · 38
PDF
Clinical response to lumacaftor-ivacaftor in patients with cystic fibrosis according to baseline lung function
2020 · Pierre-Régis Burgel, Isabelle Durieu, et al. · Journal of Cystic Fibrosis · 35
PDF
Beyond borders: cystic fibrosis survival between Australia, Canada, France and New Zealand
2022 · Adèle Coriati, Xiayi Ma, et al. · Thorax · 32
Pregnancy outcome in women with cystic fibrosis‐related diabetes
2017 · Quitterie Reynaud, Stéphanie Poupon‐Bourdy, et al. · Acta Obstetricia Et Gynecologica Scandinavica · 29
PDF
Registre Français de la Mucoviscidose. Bilan des données 2009
2011 · Gil Bellis, Marie-Hélène Cazes, et al. · HAL · 27
Optimization of the French cystic fibrosis newborn screening programme by a centralized tracking process
2017 · Anne Munck, Dominique Delmas, et al. · Journal of Medical Screening · 21
Cancer incidence and prevalence in cystic fibrosis patients with and without a lung transplant in France
2022 · Christine Rousset-Jablonski, Faustine Dalon, et al. · Frontiers in Public Health · 18
PDF
Temporal trends in healthcare resource use and associated costs of patients with cystic fibrosis
2021 · Isabelle Durieu, Faustine Dalon, et al. · Journal of Cystic Fibrosis · 18
Cumulative Incidence and Risk Factors for Severe Coronavirus Disease 2019 in French People With Cystic Fibrosis
2022 · Harriet Corvol, Sandra de Miranda, et al. · Clinical Infectious Diseases · 17
PDF
Works count: 84
Citation count: 2,163
H-index: 21
I10-index: 30
Year
Topic
Type